Farglitazar, 196808-45-4 Sole GMP Manufacturer
Farglitazar, 196808-45-4 stable novel crystalline or amorphous form both we have, Farglitazar, 196808-45-4no any IP problem. Farglitazar, 196808-45-4 DMF filling, free sample of Farglitazar, 196808-45-4.
EOS Med Chem have already carried out Farglitazar, 196808-45-4 batch production, also have completed the development of quality standards and process validation. The stable process is the guarantee of product quality. For Farglitazar, 196808-45-4 , we use HPLC-UV detection instead of other companies' HPLC-ELSD test, Our detection method is more sensitive.
Below is Farglitazar, 196808-45-4 Intermeidates list, most from GMP plant:
Farglitazar 196808-45-4, CAS 196808-45-4 Intermediate, 3580-38-9, stock 9.3kg, assay 98.4%, White powder.
Farglitazar 196808-45-4, CAS 196808-45-4 Intermediate, 196810-09-0, stock 8.1kg, assay 98.2%, White powder.
Farglitazar 196808-45-4, CAS 196808-45-4 Intermediate, 103788-65-4, stock 3.3kg, assay 98.5%, White powder.
Farglitazar 196808-45-4, CAS 196808-45-4 Intermediate, 196810-20-5, stock 2.2kg, assay 98.3%, White powder.
Farglitazar, 196808-45-4 HNMR, MASS, COA, MSDS we have.
Farglitazar, 196808-45-4, free sample, welcome to ask:
2019 CHINA CPHI E2A62
2019 WORLD CPHI 101C45
FDA 2015-2018 New API and Intermediates, Clinical Phase II, III Intermediates, GMP Custom synthesis, DMF filling, I am big.
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
Farglitazar, 196808-45-4 stable novel crystalline or amorphous form both we have, Farglitazar, 196808-45-4no any IP problem. Farglitazar, 196808-45-4 DMF filling, free sample of Farglitazar, 196808-45-4.
EOS Med Chem have already carried out Farglitazar, 196808-45-4 batch production, also have completed the development of quality standards and process validation. The stable process is the guarantee of product quality. For Farglitazar, 196808-45-4 , we use HPLC-UV detection instead of other companies' HPLC-ELSD test, Our detection method is more sensitive.
Below is Farglitazar, 196808-45-4 Intermeidates list, most from GMP plant:
Farglitazar 196808-45-4, CAS 196808-45-4 Intermediate, 3580-38-9, stock 9.3kg, assay 98.4%, White powder.
Farglitazar 196808-45-4, CAS 196808-45-4 Intermediate, 196810-09-0, stock 8.1kg, assay 98.2%, White powder.
Farglitazar 196808-45-4, CAS 196808-45-4 Intermediate, 103788-65-4, stock 3.3kg, assay 98.5%, White powder.
Farglitazar 196808-45-4, CAS 196808-45-4 Intermediate, 196810-20-5, stock 2.2kg, assay 98.3%, White powder.
Farglitazar, 196808-45-4, free sample, welcome to ask:
2019 CHINA CPHI E2A62
2019 WORLD CPHI 101C45
FDA 2015-2018 New API and Intermediates, Clinical Phase II, III Intermediates, GMP Custom synthesis, DMF filling, I am big.
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
